Retatrutide
Triple-receptor research compound. GLP-1 / GIP / glucagon pathway investigation.
RESTRICTED ACCESS
All products on this site are research chemicals sold strictly for laboratory and analytical purposes. Not for human or animal consumption. Confirm the following to enter.
I do not agree, exitSEXUAL HEALTH
Synthetic cyclic heptapeptide melanocortin-receptor agonist. Sexual-response pathway research.
ABOUT THIS COMPOUND
PT-141 (bremelanotide) is a synthetic cyclic heptapeptide that engages the melanocortin receptors, primarily MC3R and MC4R. It is widely investigated for sexual-response pathway research and is the most-studied melanocortin-receptor agonist in the modern literature.
Each lot is solid-phase synthesized in our U.S. facility, HPLC-verified above 99% purity, and lyophilized under inert atmosphere for stable storage.
SPECIFICATIONS
RESEARCH APPLICATIONS
All applications are investigative. This compound is sold for research-use only and is not for human or animal consumption.
QUALITY ASSURANCE
A current-lot Certificate of Analysis is available for every compound. Email us with the product and lot number; we'll send the documentation. Read about our lab testing →
YOU MAY ALSO RESEARCH
QUESTIONS?
Lot questions, COA requests, institutional accounts, reach the team directly.
CONTACT US